Leukemia Clinical Trial
Official title:
Evaluation of the Effect of Web-Based Education Provided to Parents of Children With Leukemia on Parents' Knowledge Level, Satisfaction and Self-Efficacy
Following and implementing innovations and current developments in care practices for children diagnosed with leukemia and their parents will allow the quality of care to increase. The purpose of this research is to evaluate the effect of web-based education given to parents of children diagnosed with leukemia on their knowledge level, satisfaction and self-efficacy. The research is a single-blind randomized controlled experimental research type. The research will be conducted in a single center, Ankara Bilkent City Hospital MH4 Children's Hospital Hematology-Oncology Clinics and Leukemia Polyclinic. The population of the research consists of parents of children diagnosed with leukemia between the ages of 2-18 who are followed and treated in the specified places. The sample of the research consists of 72 participants, 36 in the experimental group (the group that received web-supported training) and 36 in the control group (the group that continued routine treatment). The consent of the parents who meet the research criteria and voluntarily agree to participate in the study will be obtained with the "Informed Voluntary Consent Form" and the parents in both the experimental group and the control group will be given the "Child and Parent Introductory Information Form", "Child with Leukemia Parent Information Level Pre-Test Evaluation Form". ", "Generalized Perceived Self-Efficacy Scale" will be applied. Once the sufficient number is reached, web-based training will be provided to the parents in the experimental group. "Parents of Children with Leukemia Knowledge Level Post-Test Evaluation Form", "Generalized Perceived Self-Efficacy Scale" and "Web-Based Parents of Children with Leukemia Training Satisfaction Evaluation Form" will be applied to the parents who complete the training. No intervention will be made to the parents in the control group, and the children will continue their routine care and treatment process. The "Child with Leukemia Parent Knowledge Level Posttest Evaluation Form" and the "Generalized Perceived Self-Efficacy Scale" will also be applied to the parents in the control group.
Status | Recruiting |
Enrollment | 72 |
Est. completion date | April 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Years to 18 Years |
Eligibility | Inclusion Criteria: - Volunteering to participate in the research, - Being 18 years or older, - Being directly responsible for the child's care, - Not having any physical or mental illness, - Being able to use a computer or mobile phone, - Having internet access and being able to use the internet, - Being open to communication, - Being literate, - Being able to speak and understand Turkish. Exclusion Criteria: - Not following the site of membership, - Not having internet access and not being able to use the internet, - Being a foreign national, - Having vision or hearing problems, - Being illiterate, - To give up participating in the research. |
Country | Name | City | State |
---|---|---|---|
Turkey | University of Health Sciences | Ankara | Keçiören |
Lead Sponsor | Collaborator |
---|---|
Saglik Bilimleri Universitesi |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Child with Leukemia Parent Knowledge Level Pre-Test Evaluation Form | This form aims to evaluate the parents' knowledge levels before the training and the effectiveness of the training given in the post-training period. The form consists of "19" closed-ended questions about common symptoms in children with leukemia and the management of these symptoms. The evaluation form before the training (pre-test) and after the training (post-test) consists of the same questions. All of the items in questions 1, 2, 3, 6, 7, 8, 9, 11, 13, 14, 15, 16, 17, 18, 19 are correct, and questions 4, 5, 10 and 10 are correct. There is only one correct answer to question 12. Each of the items in questions 1, 2, 3, 6, 7, 8, 9, 11, 13, 14, 15, 16, 17, 18, 19 is worth 1 point, and "water and soap" in question 4 is worth 1 point. 5 points. The total knowledge score for the correct answers to the questions "once a week", 25,000 mm3 in the 10th question and "4-6 times" in the 12th question will be calculated as 1 point each. | at the time before pre-education | |
Primary | Child with Leukemia Parent Knowledge Level Post-Test Evaluation Form | This form aims to evaluate the parents' knowledge levels before the training and the effectiveness of the training given in the post-training period. The form consists of "19" closed-ended questions about common symptoms in children with leukemia and the management of these symptoms. The evaluation form before the training (pre-test) and after the training (post-test) consists of the same questions. All of the items in questions 1, 2, 3, 6, 7, 8, 9, 11, 13, 14, 15, 16, 17, 18, 19 are correct, and questions 4, 5, 10 and 10 are correct. There is only one correct answer to question 12. Each of the items in questions 1, 2, 3, 6, 7, 8, 9, 11, 13, 14, 15, 16, 17, 18, 19 is worth 1 point, and "water and soap" in question 4 is worth 1 point. 5 points. The total knowledge score for the correct answers to the questions "once a week", 25,000 mm3 in the 10th question and "4-6 times" in the 12th question will be calculated as 1 point each. | within 15 days after education | |
Primary | Web-Based Child with Leukemia Parent Education Satisfaction Evaluation Form | This form has been prepared to determine the objectives for the experimental class, the website provided for the training of the participants, and the training contents. There are "43" statements in the form, which include evaluation of the appearance of the website, its usability, the content of the website and the training provided on the website, and the level of usefulness. "18" expression in the form is prepared for the appearance and usability of the website, "12" expression is for the video explanations on the website, and "13" expression is for the modules on the website. The form was prepared according to the five-point Likert type (1 = Strongly Disagree, 2 = Disagree, 3 = Neither Agree nor Disagree, 4 = Agree, 5 = Strongly Agree). The lowest score from the form is "43" and the highest score is "215". A high score is considered to indicate that parents are satisfied with the education provided. | within 15 days after education | |
Primary | Generalized Perceived Self-Efficacy Scale | This scale aims to determine the amount of self-efficacy level of web-supported education given to children with leukemia. Scale items receive scores between 1 and 4, consist of positive items, and are evaluated based on the total score. Grading of the scale; Not true (1), somewhat true (2), more true (3), completely true (4). Total score is between 10-40. High score is considered as high self-efficacy perception. | at the time before pre-education | |
Primary | Generalized Perceived Self-Efficacy Scale | This scale aims to determine the amount of self-efficacy level of web-supported education given to children with leukemia. Scale items receive scores between 1 and 4, consist of positive items, and are evaluated based on the total score. Grading of the scale; Not true (1), somewhat true (2), more true (3), completely true (4). Total score is between 10-40. High score is considered as high self-efficacy perception. | at the within 15 days after education |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05691608 -
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
|
N/A | |
Recruiting |
NCT04092803 -
Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu
|
N/A | |
Active, not recruiting |
NCT02530463 -
Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
|
Phase 2 | |
Completed |
NCT00948064 -
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
|
Phase 2 | |
Completed |
NCT04474678 -
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
|
N/A | |
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Recruiting |
NCT03948529 -
RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation
|
Phase 2 | |
Completed |
NCT01682226 -
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
|
Phase 2 | |
Completed |
NCT00003270 -
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
|
Phase 2 | |
Active, not recruiting |
NCT02723994 -
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
|
Phase 2 | |
Terminated |
NCT02469415 -
Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)
|
Phase 2 | |
Recruiting |
NCT04856215 -
90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia
|
Phase 2 | |
Recruiting |
NCT06155188 -
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
|
N/A | |
Completed |
NCT00001637 -
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
|
Phase 2 | |
Active, not recruiting |
NCT04188678 -
Resiliency in Older Adults Undergoing Bone Marrow Transplant
|
N/A | |
Completed |
NCT02910583 -
Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)
|
Phase 2 | |
Completed |
NCT01212926 -
Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain
|
N/A | |
Terminated |
NCT00014560 -
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Recruiting |
NCT04977024 -
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
|
Phase 2 | |
Recruiting |
NCT05866887 -
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
|
N/A |